Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2021-10-22 00:00:00 ET · period of report 2021-10-20 · accession 0001567619-21-018621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-22 | 2021-10-20 | PRTA | Walker Karin L | CAO | M - OptEx | $16.97 | +23.0K | 20.0K | New | +$390.2K |
| DM | 2021-10-22 | 2021-10-20 | PRTA | Walker Karin L | CAO | S - Sale+OE | $60.25 | -23.0K | 3,885 | -86% | -$1.39M |
| DM | 2021-10-22 | 2021-10-20 | PRTA | Walker Karin L | CAO | M - OptEx | $0.00 | -23.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-20 | M | A | 3,000 | $29.81 | 23,000 | D | — | — | |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-20 | S | D | 1,700 | $60.91 | 2,185 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $60.75 to $61.71, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-20 | S | D | 2,185 | $61.94 | 0 | D | — | — | (F4) The transaction was executed in multiple trades in prices ranging from $61.84 to $62.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-20 | M | A | 20,000 | $15.04 | 20,000 | D | — | — | |
| 5 | Common | Ordinary Shares, par value $0.01 per share | 2021-10-20 | S | D | 19,115 | $60.00 | 3,885 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $59.71 to $60.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Derivative | Stock Option (right to buy) | 2021-10-20 | M | D | 20,000 | $0.00 | 90,000 | D | $15.04 · — to 2028-06-21 | 20,000 Ordinary Shares | (F5) The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on June 21, 2019, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. |
| 7 | Derivative | Stock Option (right to buy) | 2021-10-20 | M | D | 3,000 | $0.00 | 0 | D | $29.81 · — to 2024-02-04 | 3,000 Ordinary Shares | (F6) The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 4, 2015, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |